ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: PUB208

A Novel Genetic Model of Cystic Kidney Disease in the Mouse

Session Information

Category: Genetic Diseases of the Kidneys

  • 1001 Genetic Diseases of the Kidneys: Cystic

Authors

  • Waitzman, Joshua S., Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
  • Onay, Ummiye venus, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
  • Quaggin, Susan E., Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
Background

Polycystic kidney disease is the most common genetic cause of chronic kidney disease and end stage renal disease. While mutations in PKD1 and PKD2 cause most cases of autosomal dominant PKD, other genetic factors are thought to act as modifiers.

Methods

Using an ENU mutagenesis screen, we have identified a cystic kidney mutant that is transmitted in an autosomal dominant manner. We have characterized the mutation using both whole genome sequencing and RNA sequencing.

Results

Mice heterozygous for the trait develop glomerular and tubular cysts all along the nephron, but otherwise appear healthy. Mice that are homozygous for the trait develop hypoplastic, cystic kidneys, and are perinatally lethal with pulmonary hemorrhage. We have performed whole genome sequencing and identified potentially causative gene mutations on mouse chromosome 6. We have also performed RNA sequencing on kidneys from affected mice and matched controls and have identified significant changes in gene expression.

Conclusion

We present a novel mouse model of cystic kidney disease, which we have genetically and phenotypically characterized. We propose that the differentially regulated genetic elements that we have identified may represent genetic modifiers of cystic kidney disease.

Funding

  • NIDDK Support